Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

Authors: Alexandra Albertsson-Lindblad, Catja Freiburghaus, Mats Jerkeman, Sara Ek

Published: 2019-08-06

DOI: 10.1186/s40164-019-0141-1

Source: Full article

---

Abstract

No abstract found.